PTEN mutations are common in sporadic microsatellite stable colorectal cancer

Najah T. Nassif, Glenn P. Lobo, Xiaojuan Wu, Christopher J.A. Henderson, Carl D. Morrison, Charis Eng, Bin Jalaludin, Eva Segelov

Research output: Contribution to journalArticlepeer-review


The tumour suppressor gene PTEN, located at chromosome sub-band 10q23.3, encodes a dual-specificity phosphatase that negatively regulates the phosphatidylinositol 3′-kinase (PI3 K)/Akt-dependent cellular survival pathway. PTEN is frequently inactivated in many tumour types including glioblastoma, prostate and endometrial cancers. While initial studies reported that PTEN gene mutations were rare in colorectal cancer, more recent reports have shown an approximate 18% incidence of somatic PTEN mutations in colorectal tumours exhibiting microsatellite instability (MSI+). To verify the role of this gene in colorectal tumorigenesis, we analysed paired normal and tumour DNA from 41 unselected primary sporadic colorectal cancers for PTEN inactivation by mutation and/or allelic loss. We now report PTEN gene mutations in 19.5% (8/41) of tumours and allele loss, including all or part of the PTEN gene, in a further 17% (7/41) of the cases. Both PTEN alleles were affected in over half (9/15) of these cases showing PTEN genetic abnormalities. Using immunohistochemistry, we have further shown that all tumours harbouring PTEN alterations have either reduced or absent PTEN expression and this correlated strongly with later clinical stage of tumour at presentation (P = 0.02). In contrast to previous reports, all but one of the tumours with PTEN gene mutations were microsatellite stable (MSI-), suggesting that PTEN is involved in a distinct pathway of colorectal tumorigenesis that is separate from the pathway of mismatch repair deficiency. This work therefore establishes the importance of PTEN in primary sporadic colorectal cancer.

Original languageEnglish (US)
Pages (from-to)617-628
Number of pages12
Issue number2
StatePublished - Jan 15 2004
Externally publishedYes

Bibliographical note

Funding Information:
We thank the surgeons who contributed samples to the South West Sydney Colorectal Tumour Bank. We also thank Associate Professor Robyn Ward and Dr Helen Rizos for their helpful comments on the manuscript. This work was supported by grants from the South West Sydn ey Bowel Cancer Foundation and Colorectal Tumour Group, the Cancer Therapy Centre at Liverpool Hospital and a scholarship from the South West Sydney Clinical School of the University of New South Wales (to GPL). CE is a recipient of the Doris Duke Distinguished Clinical Scientist Award .


  • Immunohistochemistry
  • Loss of heterozygosity
  • Microsatellite instability
  • Mutation
  • PTEN
  • Sporadic colorectal cancer


Dive into the research topics of 'PTEN mutations are common in sporadic microsatellite stable colorectal cancer'. Together they form a unique fingerprint.

Cite this